Microbiotix, Inc.

Funding and NIH signals

• NIH award NIH awarded $299K (STTR Phase I 5R41AI195240-02, continuation, notice Aug 25, 2026); 4 NIH awards totaling $2.23M in the last 12 months. NIH RePORTER 5R41AI195240-02 (Aug 25, 2026)
  Evidence (4 events)

  • Aug 25, 2026 · NIH RePORTER 5R41AI195240-02
    Organization: MICROBIOTIX, INC; City/State: WORCESTER, MA; Project number: 5R41AI195240-02; Activity code: R41; Fiscal year: 2026; Award notice date: 2026-08-25; FY total cost (award amount): 299381; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Novel Benzyl-Piperidine antifungal agents to treat intractable Mucorales infections; Organization type: Domestic For-Profits
  • Aug 3, 2026 · NIH RePORTER 5R43AI188690-02
    Organization: MICROBIOTIX, INC; City/State: WORCESTER, MA; Project number: 5R43AI188690-02; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-03; FY total cost (award amount): 289318; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Development of well tolerated novel Inhibitors of drug resistant CMV; Organization type: Domestic For-Profits
  • May 19, 2026 · NIH RePORTER 5R42AI165102-04
    Organization: MICROBIOTIX, INC; City/State: WORCESTER, MA; Project number: 5R42AI165102-04; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-05-19; FY total cost (award amount): 969050; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Discovery of Bunyaviral Endonuclease Inhibitors for Anti Viral; Organization type: Domestic For-Profits
  • Jan 29, 2026 · NIH RePORTER 5R33EY036947-02
    Organization: MICROBIOTIX, INC; City/State: WORCESTER, MA; Project number: 5R33EY036947-02; Activity code: R33; Fiscal year: 2026; Award notice date: 2026-01-29; FY total cost (award amount): 669859; Administering IC: National Eye Institute; Project title: Translational studies to advance Filociclovir to IND submission for the treatment of adenoviral conjunctivitis and acute keratoconjunctivitis; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals